Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Economic Evaluation in Children with Intestinal Failure: Cost-utility Study of Teduglutide for Enteral Adaptation and Measurement of Health-Related Quality of Life in Patients and their Caregivers
EF 2021-22
Résumé
Intestinal failure (IF) is a devastating condition resulting in long-term parenteral nutrition support (nutrition through an intravenous line). Pediatric IF leads to significant costs to the healthcare system and patients. With increased survival of children with IF, the economic and health-related quality of life (HRQOL) impacts of IF on patients and their caregivers have been increasingly scrutinized. Furthermore, new expensive treatments that promote intestinal adaptation such as teduglutide require economic evaluation. Economic evaluations in pediatric IF are limited by a lack of pediatric HRQOL instruments. Instruments that measure HRQOL in children can be applied to both patients and their caregivers. However, agreement between these methods is not well established. A parent-child dyad approach to pediatric HRQOL has been described, which could be a valuable alternative to assess children's HRQOL.
The first objective of this study is to measure the cost-effectiveness of teduglutide in children with IF. We will perform an economic evaluation of teduglutide using a microsimulation model (model that simulates the course of a disease accounting for individual differences). The second objective is to assess the validity of alternative approaches to measuring HRQOL in children with IF. The third objective is to measure HRQOL in caregivers of children with IF and determine its correlation with the patient's HRQOL. HRQOL questionnaires will be administered during outpatient clinic visits by interview to children with IF 8 years of age or older and parents separately and then together as a dyad to assess the child's health state.
The results of the health economic evaluation of teduglutide have the potential to change clinical management and inform teduglutide funding decision-making in Canada. This study will also determine the best methods for measuring HRQOL in children and spillover effect on caregivers, an area that has been neglected in economic evaluations.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
458280
Name
Gattini Valdes Daniela
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Economic Evaluation in Children with Intestinal Failure: Cost-utility Study of Teduglutide for Enteral Adaptation and Measurement of Health-Related Quality of Life in Patients and their Caregivers
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Health Economic Analysis; Health-Related Quality Of Life; Intestinal Failure; Paediatric Health Utilities
Abstract
Intestinal failure (IF) is a devastating condition resulting in long-term parenteral nutrition support (nutrition through an intravenous line). Pediatric IF leads to significant costs to the healthcare system and patients. With increased survival of children with IF, the economic and health-related quality of life (HRQOL) impacts of IF on patients and their caregivers have been increasingly scrutinized. Furthermore, new expensive treatments that promote intestinal adaptation such as teduglutide require economic evaluation. Economic evaluations in pediatric IF are limited by a lack of pediatric HRQOL instruments. Instruments that measure HRQOL in children can be applied to both patients and their caregivers. However, agreement between these methods is not well established. A parent-child dyad approach to pediatric HRQOL has been described, which could be a valuable alternative to assess children's HRQOL.
The first objective of this study is to measure the cost-effectiveness of teduglutide in children with IF. We will perform an economic evaluation of teduglutide using a microsimulation model (model that simulates the course of a disease accounting for individual differences). The second objective is to assess the validity of alternative approaches to measuring HRQOL in children with IF. The third objective is to measure HRQOL in caregivers of children with IF and determine its correlation with the patient's HRQOL. HRQOL questionnaires will be administered during outpatient clinic visits by interview to children with IF 8 years of age or older and parents separately and then together as a dyad to assess the child's health state.
The results of the health economic evaluation of teduglutide have the potential to change clinical management and inform teduglutide funding decision-making in Canada. This study will also determine the best methods for measuring HRQOL in children and spillover effect on caregivers, an area that has been neglected in economic evaluations.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gattini Valdes, Daniela
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~